# PENTAX Medical acquires C2 Therapeutics

PENTAX Medical, a division of HOYA Group, acquired C2 Therapeutics, developer of the C2 CryoBalloon Ablation System for endoscopic ablation of Barrett's esophagus. The acquisition amount was undisclosed.

- Type: Acquisition
- Announced: 2017-01-09
- Where: Redwood City, California, United States
- Status: completed
- Products: C2 CryoBalloon Ablation System
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [PENTAX Medical](https://endata.com/companies/21306.md) (acquirer)
- [C2 Therapeutics](https://endata.com/companies/21307.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/pentax-medical-expands-interventional-endoscopy-offering-with-acquisition-of-c2-therapeutics-300388253.html), 2017-01-09: "PENTAX Medical, a division of the HOYA Group, Tokyo, Japan announced today that they have acquired C2 Therapeutics, Redwood City, CA for an undisclosed amount."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.